EN
HI
Summary
As of 25 Oct, 2026, Aspira Pathlab & Diagnostics stock price is ₹127.7. During the trading session, the stock has moved between an intraday low of ₹118.00 and an intraday high of ₹129.60. Over the last 52 weeks, Aspira Pathlab & Diagnostics has traded between ₹49.00 and ₹149.99.
The stock has recorded a trading volume of 352 shares,. Its Average Traded Price (ATP) is ₹126.88, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 200 @ ₹127.70.
Aspira Pathlab & Diagnostics has an upper circuit limit of ₹132.35 and a lower circuit limit of ₹119.75. The total value traded stands at ₹44661.76, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Aspira Pathlab & Diagnostics also offers a dividend yield of 0%.
Aspira Pathlab & Diagnostics Share Price Chart
Aspira Pathlab & Diagnostics Share Key Metrics
Volume
352.00
Market Cap
129.74 CR
LTQ@LTP
200@127.70
ATP
126.88
Var Margin
100 %
Circuit Range
119.75-132.35
Delivery %
100 %
Value
44661.76
ASM/GSM
No
Market Lot
1
Aspira Pathlab & Diagnostics Fundamentals
P/E Ratio
54.08
P/B Ratio
10.27
Div. Yield
0
Sector P/E
50.57
Sector P/B
-14.02
Sec. Div. Yield
0.2
Aspira Pathlab & Diagnostics Resistance and Support
Pivot 121.48
Resistance
First Resistance
127.96
Second Resistance
132.48
Third Resistance
138.96
Support
First Support
116.96
Second Support
110.48
Third Support
105.96
Aspira Pathlab & Diagnostics Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 23 2026 | 129.6 | 127.7 | 3.45% | 129.6 | 118 |
| Thu Oct 22 2026 | 115 | 123.44 | 2.58% | 126 | 115 |
| Wed Oct 21 2026 | 115.5 | 120.34 | 4.70% | 120.65 | 109.3 |
Aspira Pathlab & Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-12 | Others |
| 2026-08-12 | Quarterly Results & Raising of funds |
| 2026-05-23 | Audited Results |
| 2026-02-10 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-02-07 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Aspira Pathlab & Diagnostics Management
| Name | Position |
|---|---|
| Haseeb A Drabu | Chairman |
| Pankaj Shah | Managing Director & Chief Executive Officer |
Aspira Pathlab & Diagnostics Similar Stocks
Bal Pharma Ltd.
81.50
-2.90 (3.44%)
Asston Pharmaceuticals Ltd.
130.12
6.18 (4.99%)
Raaj Medisafe India Ltd.
102.00
-2.02 (1.94%)
Star Imaging and Path Lab Ltd.
74.70
-2.30 (2.99%)
Parnax Lab Ltd.
111.85
8.40 (8.12%)
Makers Laboratories Ltd.
192.00
0.00 (0.00%)
Mercury Laboratories Ltd.
731.05
1.05 (0.14%)
Himalaya Nutravedics India Ltd.
137.20
0.00 (0.00%)
Bharat Immunologicals & Biologicals Corporation Ltd.
9.29
0.11 (1.20%)
Aspira Pathlab & Diagnostics FAQs
The Buying Price of Aspira Pathlab & Diagnostics share is 127.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aspira Pathlab & Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aspira Pathlab & Diagnostics, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 54.08. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 10.27. Useful to assess the stock's value relative to its book value.
To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 50.57 & -14.02 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aspira Pathlab & Diagnostics is 129.74 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 149.99 & 49.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aspira Pathlab & Diagnostics belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ASPIRA
